Recent Updates
Recently added Catalysts
KPTI Positive Sentiment

Karyopharm to Participate at the Jefferies Healthcare Conference

Thursday, June 1, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Karyopharm Therapeutics Inc. announced its participation in the Jefferies Healthcare Conference, scheduled for June 8, 2023, at 10:00 a.m. ET in New York. The company's senior management team will engage in a fireside chat, offering insights into their operations and future goals. The event will be accessible via a live webcast and later available for replay on Karyopharm's investor website, emphasizing the company's focus on investor engagement.
Price reaction · baseline $33.9 (2023-05-31 close) · hit after-hours · clean, no other KPTI news in the window
day 0 close · peak
-2.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Karyopharm is actively participating in important conferences to engage with investors.
  • The company showcases its commitment to transparency and investor relations through live webcasts.
  • Participation at the Jefferies Healthcare Conference highlights Karyopharm's recognized position in the healthcare sector.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+105%
120-day peak, hindsight
Typical move
15.1%
average across 5 past catalysts
Cash runway
~8 mo
Medium dilution risk
Lead asset
Selinexor
Phase 2 · Acute Myeloid Leukemia (AML)

Full Press Release Details

NEWTON, Mass., June 1, 2023 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management team will participate at the Jefferies Healthcare Conference in a fireside chat on Thursday, June 8, 2023 at 10:00 a.m. ET in New York, NY.
A live webcast of the fireside chat can be accessed under "Events & Presentations" in the Investor section of the Company's website, http://investors.karyopharm.com/events-presentations, and will be available for replay for 90 days following the event.
About Karyopharm Therapeutics
XPOVIO® and NEXPOVIO® are registered trademarks of Karyopharm Therapeutics Inc. Any other trademarks referred to in this release are the property of their respective owners.

Frequently Asked Questions

When is Karyopharm's fireside chat at the Jefferies Conference?

The chat is scheduled for Thursday, June 8, 2023, at 10:00 a.m. ET.

Where can I watch Karyopharm's fireside chat live?

You can watch it live on the Company's website under 'Events & Presentations.'

How long will the webcast be available for replay?

The webcast will be available for replay for 90 days after the event.

What do XPOVIO® and NEXPOVIO® refer to?

XPOVIO® and NEXPOVIO® are registered trademarks of Karyopharm Therapeutics Inc.

ShareAdd on Google
Tags: KPTI Viatris Investor Conferences Healthcare Karyopharm Therapeutics Jefferies Conference investor relations cancer therapies
Last updated: Jun 1, 2023

Biotech snapshot

Cash runway
$65M liquidity · $8M/mo burn
~8 mo
Medium dilution risk
Lead asset
SelinexorPhase 2
Acute Myeloid Leukemia (AML) →

Catalyst track record

+105%
best trade around KPTI's most recent catalyst

Peak hindsight return over a 120-day window, across 5 tracked FDA/PDUFA catalysts for KPTI.

See every catalyst's timing & PoA →